Files in this item
Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
Item metadata
dc.contributor.author | Cullell, Natalia | |
dc.contributor.author | Carrera, Caty | |
dc.contributor.author | Muiño, Elena | |
dc.contributor.author | Torres-Aguila, Nuria-Paz | |
dc.contributor.author | Cárcel-Márquez, Jara | |
dc.contributor.author | González-Sánchez, Jonathan | |
dc.contributor.author | Gallego-Fabrega, Cristina | |
dc.contributor.author | Molina, Jessica | |
dc.contributor.author | Besora, Sarah | |
dc.contributor.author | Sotoca, Javier | |
dc.contributor.author | Buongiorno, Maria-Teresa | |
dc.contributor.author | Jiménez-Conde, Jordi | |
dc.contributor.author | Giralt-Steinhauer, Eva | |
dc.contributor.author | de Torres-Chacón, Reyes | |
dc.contributor.author | Montaner, Joan | |
dc.contributor.author | Mancha, Fernando | |
dc.contributor.author | Cabezas, Juan A | |
dc.contributor.author | Martí-Fàbregas, Joan | |
dc.contributor.author | Prats-Sánchez, Luis | |
dc.contributor.author | Camps-Renom, Pol | |
dc.contributor.author | Purroy, Francisco | |
dc.contributor.author | Cambray, Serafi | |
dc.contributor.author | Del Mar Freijo, María | |
dc.contributor.author | Vives-Bauzá, Cristòfol | |
dc.contributor.author | Tur, Silvia | |
dc.contributor.author | Font, Maria-Àngels | |
dc.contributor.author | López-Cancio, Elena | |
dc.contributor.author | Hernandez-Perez, Maria | |
dc.contributor.author | Obach, Victor | |
dc.contributor.author | Calleja, Ana | |
dc.contributor.author | Arenillas, Juan | |
dc.contributor.author | Rodríguez-Yáñez, Manuel | |
dc.contributor.author | Castillo, José | |
dc.contributor.author | Sobrino, Tomas | |
dc.contributor.author | Fernández-Cádenas, Israel | |
dc.contributor.author | Krupinski, Jerzy | |
dc.date.accessioned | 2020-08-17T12:30:05Z | |
dc.date.available | 2020-08-17T12:30:05Z | |
dc.date.issued | 2020-02-18 | |
dc.identifier | 269531870 | |
dc.identifier | ab177f85-f7da-48b8-9ca7-6df6e0aa39d2 | |
dc.identifier | 32071341 | |
dc.identifier | 85079587141 | |
dc.identifier.citation | Cullell , N , Carrera , C , Muiño , E , Torres-Aguila , N-P , Cárcel-Márquez , J , González-Sánchez , J , Gallego-Fabrega , C , Molina , J , Besora , S , Sotoca , J , Buongiorno , M-T , Jiménez-Conde , J , Giralt-Steinhauer , E , de Torres-Chacón , R , Montaner , J , Mancha , F , Cabezas , J A , Martí-Fàbregas , J , Prats-Sánchez , L , Camps-Renom , P , Purroy , F , Cambray , S , Del Mar Freijo , M , Vives-Bauzá , C , Tur , S , Font , M-À , López-Cancio , E , Hernandez-Perez , M , Obach , V , Calleja , A , Arenillas , J , Rodríguez-Yáñez , M , Castillo , J , Sobrino , T , Fernández-Cádenas , I & Krupinski , J 2020 , ' Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain ' , Scientific Reports , vol. 10 , 2806 . https://doi.org/10.1038/s41598-020-59641-9 | en |
dc.identifier.issn | 2045-2322 | |
dc.identifier.other | PubMedCentral: PMC7028945 | |
dc.identifier.other | ORCID: /0000-0002-9502-9310/work/78892083 | |
dc.identifier.uri | https://hdl.handle.net/10023/20478 | |
dc.description.abstract | Acenocoumarol is an oral anticoagulant with significant interindividual dose variations. Variants in CYP2C9 and VKORC1 have been associated with acenocoumarol maintenance dose. We analysed whether any of the 49 polymorphisms in CYP2C9 and VKORC1 previously associated with acenocoumarol maintenance dose in a Genome-Wide Association study (GWAs) in Dutch population are associated with stroke recurrence, intracranial haemorrhage (ICH) and acenocoumarol maintenance dose in a Spanish population. We performed a GWAs using Human Core Exome-chip (Illumina) in 78 patients stroke patients treated with acenocoumarol for secondary prevention enrolled as part of the prospective investigator-initiated study (IIS) SEDMAN Study. Patients were followed-up a median of 12.8 months. Three and eight patients had recurrent stroke and ICH events, respectively. We found 14 of the 49 published variants associated with acenocoumarol maintenance dose (p < 0.05). Six polymorphisms were associated with stroke recurrence and four variants with ICH (p < 0.05). In conclusion, variants in VKORC1 and CYP2C9 are associated with acenocoumarol maintenance dose, stroke recurrence and ICH in a Spanish cohort. These results highlight the relevance of studying pharmacogenetics associated with efficacy and safety of anticoagulant drugs and justify studies with larger sample size and different ethnic populations. | |
dc.format.extent | 7 | |
dc.format.extent | 1060855 | |
dc.language.iso | eng | |
dc.relation.ispartof | Scientific Reports | en |
dc.subject | QH301 Biology | en |
dc.subject | QH426 Genetics | en |
dc.subject | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | en |
dc.subject | NDAS | en |
dc.subject.lcc | QH301 | en |
dc.subject.lcc | QH426 | en |
dc.subject.lcc | RC0321 | en |
dc.title | Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Biology | en |
dc.identifier.doi | 10.1038/s41598-020-59641-9 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.